Original Research

Published on 12 Apr 2023

Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system

in Cancer Endocrinology

Liang Xu
Xinyi Yang
Wenxuan Xiang
Pengbo Hu
Xiuyuan Zhang
Zhou Li
Yiming Li
Yongqing Liu
Yuhong Dai
Yan Luo

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1155307

989 views

Original Research

Published on 12 Apr 2023

Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype

in Cancer Endocrinology

Jie Zhou
Wei-Ran Wang
Hui-Fang Zhang
Qi-Qi Gao
Wei-Bin Wang
Jian-Hua Zhu
Yu-Shuai Han
Jing Chen
Tong-Hui Ma
Xiao-Yan Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1138100

1,870 views
2 citations

Original Research

Published on 11 Apr 2023

Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment

in Cancer Endocrinology

Shuaiwu Luo
Jiakun Wang
Linquan Wu
Cong Wang
Jun Yang
Min Li
Ligan Zhang
Jin Ge
Chi Sun
Enliang Li

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1123642

998 views
1 citation

Systematic Review

Published on 11 Apr 2023

Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis

in Cancer Endocrinology

Lei Zhong
Jifeng Liu
Shuo Liu
Guang Tan

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1116582

2,655 views
2 citations

Original Research

Published on 06 Apr 2023

Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming

in Cancer Endocrinology

Shengji Cao
Sitong Xiao
Jingyang Zhang
Shijun Li

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1147366

2,224 views
2 citations

Original Research

Published on 05 Apr 2023

Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer

in Cancer Endocrinology

Jinxing Wei
XiaoMing Wu
Shuohao Wang
Siqing Liu
Xia Gao

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1138457

1,936 views

Original Research

Published on 05 Apr 2023

Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patients

in Cancer Endocrinology

Ji Wu
Jiabin Zhou
Yibo Chai
Chengjian Qin
Yuankun Cai
Dongyuan Xu
Yu Lei
Zhimin Mei
Muhua Li
Lei Shen

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1172182

3,013 views

Review

Published on 05 Apr 2023

Anoikis in phenotypic reprogramming of the prostate tumor microenvironment

in Cancer Endocrinology

Prerna R. Nepali
Natasha Kyprianou

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1160267

3,223 views
3 citations

Original Research

Published on 04 Apr 2023

Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals

in Cancer Endocrinology

Zhen Yang
Caiyun Liu
Kaiming Leng
Lianshuang Liu
Guangjun Shi

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1025485

930 views

Original Research

Published on 04 Apr 2023

Long-term organoid culture of a small intestinal neuroendocrine tumor

in Cancer Endocrinology

Sabrina D’Agosto
Elena Fiorini
Francesco Pezzini
Pietro Delfino
Michele Simbolo
Caterina Vicentini
Silvia Andreani
Paola Capelli
Borislav Rusev
Rita T. Lawlor

Frontiers in Endocrinology

doi 10.3389/fendo.2023.999792

2,649 views

Original Research

Published on 31 Mar 2023

ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer

in Cancer Endocrinology

Wenbo Zou
Hao Wang
Dingguo Wu
Yunyang Wu
Kuiping Zhou
Yuanshu Lian
Gengyun Chang
Yuze Feng
Jifeng Liang
Gao Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1093042

3,432 views
1 citation

Systematic Review

Published on 31 Mar 2023

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis

in Cancer Endocrinology

Li Gu
Xurui Li
Wentao Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1157857

3,187 views

Original Research

Published on 29 Mar 2023

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer

in Cancer Endocrinology

Song Yi Bae
Hannah E. Bergom
Abderrahman Day
Joseph T. Greene
Zoi E. Sychev
Gabrianne Larson
Eva Corey
Stephen R. Plymate
Tanya S. Freedman
Justin H. Hwang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1093332

2,282 views

Review

Published on 28 Mar 2023

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers

in Cancer Endocrinology

Maritza P. Garrido
Andrea Hernandez
Margarita Vega
Eyleen Araya
Carmen Romero

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1143261

2,512 views
3 citations

Editorial

Published on 28 Mar 2023

Editorial: Hormones and receptors in breast cancer

in Cancer Endocrinology

Cinthia Rosemblit
Norbert Nass
María Celeste Díaz Flaqué

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1185615

626 views

Review

Published on 27 Mar 2023

Emerging role of substance and energy metabolism associated with neuroendocrine regulation in tumor cells

in Cancer Endocrinology

Yingying Liu
Renjun Gu
Murong Gao
Yangwa Wei
Yu Shi
Xu Wang
Yihuang Gu
Xin Gu
Hongru Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1126271

2,246 views

Navigation group

Articles

Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system

Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype

Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment

Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis

Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming

Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer

Novel prognostic features and personalized treatment strategies for mitochondria-related genes in glioma patients

Anoikis in phenotypic reprogramming of the prostate tumor microenvironment

Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals

Long-term organoid culture of a small intestinal neuroendocrine tumor

ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers

Editorial: Hormones and receptors in breast cancer

Emerging role of substance and energy metabolism associated with neuroendocrine regulation in tumor cells